Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results.

Di Serio F, Fontana A, Loizzi M, Capotorto G, Maggiolini P, Mera E, Bisceglia L, Molinini R.

Clin Chem Lab Med. 2007;45(5):634-8.

PMID:
17484626
[PubMed - indexed for MEDLINE]
2.

MESOMARK: a potential test for malignant pleural mesothelioma.

Beyer HL, Geschwindt RD, Glover CL, Tran L, Hellstrom I, Hellstrom KE, Miller MC, Verch T, Allard WJ, Pass HI, Sardesai NY.

Clin Chem. 2007 Apr;53(4):666-72. Epub 2007 Feb 8.

PMID:
17289801
[PubMed - indexed for MEDLINE]
Free Article
3.

Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.

Pass HI, Wali A, Tang N, Ivanova A, Ivanov S, Harbut M, Carbone M, Allard J.

Ann Thorac Surg. 2008 Jan;85(1):265-72; discussion 272.

PMID:
18154821
[PubMed - indexed for MEDLINE]
4.

Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure.

Rodríguez Portal JA, Rodríguez Becerra E, Rodríguez Rodríguez D, Alfageme Michavila I, Quero Martínez A, Diego Roza C, León Jiménez A, Isidro Montes I, Cebollero Rivas P.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):646-50. doi: 10.1158/1055-9965.EPI-08-0422. Epub 2009 Feb 3.

PMID:
19190155
[PubMed - indexed for MEDLINE]
Free Article
5.

Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer.

Schneider J, Hoffmann H, Dienemann H, Herth FJ, Meister M, Muley T.

J Thorac Oncol. 2008 Nov;3(11):1317-24. doi: 10.1097/JTO.0b013e318187491c.

PMID:
18978568
[PubMed - indexed for MEDLINE]
6.

Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels.

Rai AJ, Flores RM, Mathew A, Gonzalez-Espinoza R, Bott M, Ladanyi M, Rusch V, Fleisher M.

Clin Chem Lab Med. 2010 Feb;48(2):271-8. doi: 10.1515/CCLM.2010.066.

PMID:
20131968
[PubMed - indexed for MEDLINE]
7.

MESOMARK kit detects C-ERC/mesothelin, but not SMRP with C-terminus.

Segawa T, Hagiwara Y, Ishikawa K, Aoki N, Maeda M, Shiomi K, Hino O.

Biochem Biophys Res Commun. 2008 May 9;369(3):915-8. doi: 10.1016/j.bbrc.2008.02.114. Epub 2008 Mar 5.

PMID:
18328258
[PubMed - indexed for MEDLINE]
8.

Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC/mesothelin increases its potential as a useful serum tumor marker for mesothelioma.

Shiomi K, Hagiwara Y, Sonoue K, Segawa T, Miyashita K, Maeda M, Izumi H, Masuda K, Hirabayashi M, Moroboshi T, Yoshiyama T, Ishida A, Natori Y, Inoue A, Kobayashi M, Sakao Y, Miyamoto H, Takahashi K, Hino O.

Clin Cancer Res. 2008 Mar 1;14(5):1431-7. doi: 10.1158/1078-0432.CCR-07-1613.

PMID:
18316566
[PubMed - indexed for MEDLINE]
Free Article
9.

Soluble mesothelin-related peptides (SMRP) - high stability of a potential tumor marker for mesothelioma.

Weber DG, Taeger D, Pesch B, Kraus T, Brüning T, Johnen G.

Cancer Biomark. 2007;3(6):287-92.

PMID:
18048966
[PubMed - indexed for MEDLINE]
10.

Soluble mesothelin-related protein--a blood test for mesothelioma.

Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I.

Lung Cancer. 2005 Jul;49 Suppl 1:S109-11.

PMID:
15950789
[PubMed - indexed for MEDLINE]
11.

Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case-control study.

Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K.

Lung Cancer. 2008 Aug;61(2):235-43. doi: 10.1016/j.lungcan.2007.12.025. Epub 2008 Feb 20.

PMID:
18281122
[PubMed - indexed for MEDLINE]
12.

Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study.

Park EK, Sandrini A, Yates DH, Creaney J, Robinson BW, Thomas PS, Johnson AR.

Am J Respir Crit Care Med. 2008 Oct 15;178(8):832-7. doi: 10.1164/rccm.200802-258OC. Epub 2008 Jun 26.

PMID:
18583574
[PubMed - indexed for MEDLINE]
13.

Individual predictors of increased serum mesothelin in asbestos-exposed workers.

Filiberti R, Marroni P, Mencoboni M, Mortara V, Caruso P, Cioè A, Michelazzi L, Merlo DF, Bruzzone A, Bobbio B, Del Corso L, Galli R, Taveggia P, Dini G, Spigno F.

Med Oncol. 2013 Mar;30(1):422. doi: 10.1007/s12032-012-0422-6. Epub 2013 Jan 1.

PMID:
23277285
[PubMed - indexed for MEDLINE]
14.

Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma.

Cristaudo A, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, Ambrosino N, Chella A, Lucchi M, Mussi A, Foddis R.

J Thorac Oncol. 2011 Sep;6(9):1587-93. doi: 10.1097/JTO.0b013e31821e1c08.

PMID:
21642872
[PubMed - indexed for MEDLINE]
15.

Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population.

Park EK, Thomas PS, Creaney J, Johnson AR, Robinson BW, Yates DH.

Clin Chem Lab Med. 2010 Jun;48(6):869-74. doi: 10.1515/CCLM.2010.165.

PMID:
20345230
[PubMed - indexed for MEDLINE]
16.

Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma.

Creaney J, Olsen NJ, Brims F, Dick IM, Musk AW, de Klerk NH, Skates SJ, Robinson BW.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2238-46. doi: 10.1158/1055-9965.EPI-10-0346. Epub 2010 Jul 22.

PMID:
20651076
[PubMed - indexed for MEDLINE]
Free Article
17.

Sensitivity of urinary mesothelin in patients with malignant mesothelioma.

Creaney J, Musk AW, Robinson BW.

J Thorac Oncol. 2010 Sep;5(9):1461-6.

PMID:
20815094
[PubMed - indexed for MEDLINE]
18.

Is soluble mesothelin-related protein an upfront predictive marker of pleural mesothelioma? A prospective study on Italian workers exposed to asbestos.

Filiberti R, Marroni P, Spigno F, Merlo DF, Mortara V, Caruso P, Cioè A, Michelazzi L, Bruzzone A, Bobbio B, Simonassi C, Del Corso L, Galli R, Racchi O, Dini G, Linares R, Mencoboni M.

Oncology. 2014;86(1):33-43. doi: 10.1159/000355687. Epub 2013 Dec 21.

PMID:
24401539
[PubMed - indexed for MEDLINE]
19.

Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer.

Cristaudo A, Foddis R, Vivaldi A, Guglielmi G, Dipalma N, Filiberti R, Neri M, Ceppi M, Paganuzzi M, Ivaldi GP, Mencoboni M, Canessa PA, Ambrosino N, Chella A, Mutti L, Puntoni R.

Clin Cancer Res. 2007 Sep 1;13(17):5076-81.

PMID:
17785560
[PubMed - indexed for MEDLINE]
Free Article
20.

Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos.

Gube M, Taeger D, Weber DG, Pesch B, Brand P, Johnen G, Müller-Lux A, Gross IM, Wiethege T, Weber A, Raithel HJ, Kraus T, Brüning T.

Arch Toxicol. 2011 Mar;85(3):185-92. doi: 10.1007/s00204-010-0580-2. Epub 2010 Aug 25.

PMID:
20737138
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk